Table 2 Demographic Data of Percutaneous Patients
Variable | Total | LS | MS | SS | MS7 | LM |
|---|---|---|---|---|---|---|
Patients (n) | 28 | 4 | 8 | 9 | 4 | 3 |
Age (years) | 26.55 ± 22.5 (1–63) | 25 ± 17 | 41.8 ± 13.4 | 3.9 ± 1.6 | 24.4 ± 26.6 | 43 ± 9.6 |
Gender (F/M) | 23/5 | 3/1 | 6/2 | 7/2 | 4/0 | 3/0 |
Weight (kg) | 41.8 ± 22.3 (11–76) | 48 ± 26 | 54.8 ± 16.6 | 16.3 ± 3.3 | 42 ± 18.7 | 66 ± 2.5 |
Maximum ASD size (mm) | 1.1 ± 6.25 (3–23) | 19 ± 3.5 | 11.5 ± 3.41 | 3.5 ± 0.6 | 12.3 ± 1.3 | 19 ± 4.2 |
Device Size (mm) | 20.9 ± 6 (6–35) | 25 ± 5 | 22.8 ± 6 | PF1818 | 17.5 ± 3 | 28 ± 2 |
Ordinary Device (n) | 15 | 4 | 5 | 1 | 2 | 3 |
PF Device (n) | 13 | 0 | 3 | 8 | 2 | 0 |
Redeployment (n) | 6 | 1 | 2 | 1 | 1 | 1 |
ICMT (min) | 20 ± 11 (3–50) | 23.3 ± 13.8 | 27 ± 13.5 | 20.7 ± 8.9 | 8.7 ± 6 | 19 ± 9.5 |
Procedural Time (min) | 29.7 ± 17.7 (10–75) | 28.6 ± 17.6 | 33 ± 20.6 | 29 ± 17 | 37.7 ± 23.9 | 21 ± 9 |
Complete Occlusion-rate 3 month (%) | 92.6% | 100% | 87.7% | 100% | 75% | 100% |